Adult patients who seek audiological services may be taking prescription medication(s). This may include medications for depression. As such, a recent report by Elgaddal and colleagues (2025) may be pertinent.
The report used data from the 2023 National Health Interview Survey, to estimate the percentage of adults (18 years of age and older) in the United States who take prescription medication for depression.
These authors estimated that 11.4 percent of adults used prescription medication for depression. The percentage of women (15.3 percent) taking such medication was significantly greater than men (7.4 percent). Additionally, those aged 45–64 years (12.1 percent) and 65–74 years (12.4 percent) were significantly more likely to be taking prescription medication for depression than those aged 18–44 years (10.7 percent).
Those who lived alone (14.4 percent) versus with others (10.9 percent) and those with a disability (28.2 percent) versus those without any disabilities (9.7 percent) were also more likely to be taking prescription medication for depression. Adults were considered to have a disability if they responded “a lot of difficulty” or “cannot do at all or unable to do” to at least one of the six domains on the Washington Group Short Set of Functioning (REF). These domains include seeing, hearing, mobility, communication, cognition, and self-care.
These authors also reported that the percentage of people who took prescription medication for depression varied significantly by race and Hispanic origin, family income, level of education, region, and level of urbanization of residence.
References
Elgaddal, N., Weeks, J. D., & Mykyta, L. (2025). Characteristics of adults age 18 and older who took prescription medication for depression: United States, 2023. NCHS Data Brief, 528,1-9.
Washington Group on Disability Statistics. (2022). WG Short Set on Functioning (WG-SS).
Recent Posts
Update on Hearing Device Services Codes
As released publicly in the March 10, 2026, AMA’s Errata & Technical Corrections CPT 2026, the parentheticals related to code 92628 (Evaluation for hearing candidacy)…
Intratympanic Steroid Therapy as a Salvage Treatment for Sudden Sensorineural Hearing Loss
Fernandez et al. (2026) completed a retrospective analysis of 86 patients seen between 2019 and 2024 with sudden sensorineural hearing loss (SSNHL). This analysis compared…
Clinical Superiority of Belly-Tendon Montage Over Others for Recording Air-Conducted Ocular Vestibular Evoked Myogenic Potential
In a recent study published by Raveendran and Singh (2026), a number of ocular vestibular evoked myogenic potential (oVEMP) electrode montages were compared. This study…


